L-DEP/DEP Regimen and PD-1 Antibody as a Treatment for Relapse/Refractory EBV-HLH

Clinical trial NCT05315336 · UNKNOWN

Trial details

NCT number: NCT05315336
Sponsor: Beijing Friendship Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hemophagocytic Lymphohistiocytosis

Start date: 2022-06-01
Primary completion: 2025-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.